Cell-surface Expression of Lymphocyte Activation Markers in Myasthenia Gravis
Authors:
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 31 (1) , 55-66
Abstract
An analysis of the cell-surface expression of activation markers on B- and T-cells was done to compare patients with myasthenia gravis (MG) and healthy non-myasthenic controls. Marker expression was determined by immunostaining of peripheral blood mononuclear cells (PBMC) isolated from MG patients and from controls. The percentage of B-cells in PBMC that expressed CD71, a transferrin receptor, was significantly greater in patients compared to controls, particularly, in patients who were seropositive for acetylcholine receptor-specific antibodies. When subgroups of MG patients were studied, our data showed that within the first year after disease onset, patients had a significantly higher percentage of T-cells in PBMC that were CD25+ (interleukin-2 receptor α) and CD26+ (dipeptidyl peptidase IV ectoenzyme) in comparison to patients with disease symptoms for longer than one year and to healthy controls. Our data also showed that patients with generalized MG had significantly lower percentages of γ/δ T-cells in peripheral blood compared to healthy controls. The results of this study demonstrate important differences in the cell-surface expression of lymphocyte markers between MG patients and healthy non-myasthenic controls. In addition, differences between subgroups of patients demonstrate that patients with MG are heterogeneous in clinical presentation and in immunological parameters.Keywords
This publication has 47 references indexed in Scilit:
- Aerosol Insulin Induces Regulatory CD8 γδ T Cells That Prevent Murine Insulin-dependent DiabetesJournal of Experimental Medicine, 1996
- RECOGNITION BY γ/δ T CELLSAnnual Review of Immunology, 1996
- Phenotypic and Functional Abnormalities of B Cells in Myasthenia GravisAnnals of the New York Academy of Sciences, 1993
- Lymphocyte Subsets of the Peripheral Blood in Myasthenia Gravis Determined by Two-Color FlowcytometryAutoimmunity, 1990
- Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritisArthritis & Rheumatism, 1987
- TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors.Journal of Experimental Medicine, 1985
- Subsets of lymphoid cells in blood and thymus in myasthenia gravisJournal of Neuroimmunology, 1983
- Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia GravisNew England Journal of Medicine, 1982
- Thymic Muscle Cells Bear Acetylcholine Receptors: Possible Relation to Myasthenia GravisScience, 1977
- Myasthenia Gravis and the ThymusAnnual Review of Medicine, 1971